Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Katja Suomi"'
Autor:
Sergey G. Kuznetsov, Alexander Ianevski, Evgeny Kulessky, Karoliina Laamanen, Elina Lehtinen, Maria Nurmi, Swapnil Potdar, Jani Saarela, Katja Suomi, Laura Turunen, Krister Wennerberg, Päivi Tammela
Publikováno v:
Cancer Research. 79:2153-2153
Introduction/Purpose: Cancer therapy is increasingly moving towards individualized care and therapy, but there are still gaps between what is known and described on the molecular level about cancers and what is applied in the clinic. In an attempt to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e8a975029fbfcc1aee3f03ba217ac8d4
https://doi.org/10.1158/1538-7445.am2019-2153
https://doi.org/10.1158/1538-7445.am2019-2153
Autor:
Disha Malani, Olli Kallioniemi, Alun Parson, Satu Mustjoki, Minna Suvela, Caroline A. Heckman, Katja Suomi, Karoliina Laamanen, Laura Turunen, Kimmo Porkka, Ashwni Kumar, Bjørn Tore Gjertsen, Imre Vastrik, Muntasir Mamun Majumder, Pekka Ellonen, Evgeny Kulesskiy, Maija Wolf, Maria Nurmi, Oscar Brück, Astrid Muruimägi, Swapnil Potdar, Sari Kytölä, Krister Wennerberg, Samuli Eldfors, Tero Aittokallio, Simon Anders, Riikka Karjalainen, Bhagwan Yadav, Jani Saarela, Siv Knappila, Matti Kankainen, Aino Palva, Elina Lehtinen, Mika Kontro, Pirkko Mattila
Publikováno v:
Cancer Research. 79:458-458
Acute myeloid leukemia (AML) is an aggressive disease of clonal hematopoietic progenitor cells. Here, we applied ex-vivo drug sensitivity and resistance testing on AML patient cells with 362 emerging and 153 approved cancer drugs together with genomi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12a633a44f8cc531db67e03f23b7b7c5
https://doi.org/10.1158/1538-7445.am2019-458
https://doi.org/10.1158/1538-7445.am2019-458
Autor:
Jenni Mäki-Jouppila, Jani Saarela, Elina Huovari, Tiina E. Kähkönen, Mari I. Suominen, Jenni Bernoulli, Päivi Östling, Jussi M. Halleen, Katja Suomi, Sanna Timonen, Maria Nurmi, Swapnil Potdar, Katja M. Fagerlund
Publikováno v:
Cancer Research. 77:3838-3838
Multiple myeloma (MM) is the second most common hematologic malignancy that originates from B-cells (plasma cells) and causes 2% of cancer-related deaths. Symptoms of MM include bone pain caused by multiple osteolytic lesions, pathologic fractures, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2fc89944b21b18f42079f448df35d016
https://doi.org/10.1158/1538-7445.am2017-3838
https://doi.org/10.1158/1538-7445.am2017-3838
Autor:
Mari I. Suominen, Johanna Tuomela, Jenni Bernoulli, Päivi Östling, Elina Huovari, Katja Suomi, Jani Saarela, Sanna Timonen, Jussi M. Halleen, Jenni Mäki-Jouppila, Swapnil Potdar, Katja M. Fagerlund
Publikováno v:
Cancer Research. 77:4207-4207
Prostate cancer (PC) is the most common malignancy in men and the second leading cause of cancer-related deaths. The majority of the PCs are classified as adenocarcinomas characterized by the expression of androgen receptor (AR) and prostate-specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0cf82ef4a8fd782a58771a466f5acd0
https://doi.org/10.1158/1538-7445.am2017-4207
https://doi.org/10.1158/1538-7445.am2017-4207
Autor:
Riikka Juvonen, Kaisa Poutanen, Otto Savolainen, Kati Katina, Rossana Coda, Katja Suomi, Kati Hanhineva
Publikováno v:
Savolainen, O I, Coda, R, Suomi, K, Katina, K, Juvonen, R, Hanhineva, K & Poutanen, K 2014, ' The role of oxygen in the liquid fermentation of wheat bran ', Food Chemistry, vol. 153, pp. 424-431 . https://doi.org/10.1016/j.foodchem.2013.12.062
The extensive use of wheat bran as a food ingredient is limited due to its bitter taste and hard texture. To overcome these, some preprocessing methods, such as fermentation with yeast and lactic acid bacteria or enzymatic treatments have been propos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::002ed51a09a836aac2dd28a20867a759
https://pubmed.ncbi.nlm.nih.gov/24491749
https://pubmed.ncbi.nlm.nih.gov/24491749